Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
LHX8 antisense RNA 1 (LHX8-AS1) is a long non-coding antisense RNA transcribed from the opposite strand of the LHX8 gene locus. Antisense lncRNAs like LHX8-AS1 can regulate the expression of their sense gene (LHX8) through various mechanisms, including chromatin modification, transcriptional interference, and RNA stability control. Although antisense lncRNAs are increasingly recognized as important regulators in development and disease, there are no reported therapeutic drugs targeting LHX8-AS1, nor are there established disease associations or roles as a biomarker. LHX8-AS1 is classified molecularly as an antisense lncRNA and primarily functions in gene regulation[2][4]. If further research establishes additional aliases, disease roles, or interacting drugs, the above entries should be updated accordingly. Current literature acknowledges the critical regulatory roles of antisense lncRNAs in other systems, including cancer, but LHX8-AS1 itself has not yet been implicated directly in these processes[2][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on LHX8 antisense RNA 1 (LHX8-AS1).